Leukocyte Interleukin · LI

What is Leukocyte Interleukin?

Leukocyte Interleukin (Multikine) is a cocktail of synthetic cytokines including IL-1, IL-2, IL-6, TNF-alpha, and interferon gamma. It activates immune responses including antibody production and cytokine modulation. It is studied in squamous cell carcinoma of the head and neck and condyloma as neoadjuvant therapy.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as

LI, Multikine

Drug type

Recombinant protein

Mechanism

Immune activation

Pathways

immune_activation, cytokine signaling

Therapy area

Infectious disease, Oncology

Developer

CEL-SCI Corporation (CVM)

FDA status

Investigational, not approved in the US. Most advanced trial: Phase 3

🧪 Clinical trials

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

CondylomaPerianal WartsSquamous Cell Carcinoma of the Oral CavitySquamous Cell Carcinoma of the Soft Palate

Sources

• NCI Thesaurus
• ClinicalTrials.gov NCT01265849
• ClinicalTrials.gov NCT02115919
• ClinicalTrials.gov NCT02115919

Updated Oct 3, 2026. Something wrong or missing? Report it on the CVM page.